… 15% of all lung cancers, representing approximately 372 … any other platinum regimens; topotecan; lurbinectedin; taxane; cyclophosphamide, … Institute. Small cell lung cancer treatment (PDQ®)–health … of Lung Cancer—what limits limited disease? Lung Cancer. 2002 …

… -drug conjugate being tested for lung cancer, a spokesperson for the companies … patients with relapsed small cell lung cancer. Participants were treated with I … an active chemotherapy comparator, including topotecan, amrubicin and lurbinectedin. In a …

… highlighted new small cell lung cancer therapies, including T cell … of three chemotherapy options: topotecan, lurbinectedin or amrubicin. The … of recurrent, small cell lung cancer.” In addition, Rudin … with recurrent small cell lung cancer. The study involved …

… with extensive stage small cell lung cancer (ES-SCLC) with … aggressive nature, small cell lung cancer has long been particularly … of lurbinectedin (n = 47), topotecan (n = 185), or amrubicin … for extensive-stage small-cell lung cancer. FDA. November 19, 2025 …

… Chemotherapy in Relapsed Small Cell Lung Cancer (DeLLphi-304) ClinicalTrials.gov … standard of care chemotherapy—either topotecan, lurbinectedin, or amrubicin—(n = … Chemotherapy in Relapsed Small Cell Lung Cancer (DeLLphi-304). ClinicalTrials.gov …

… (Zepzelca; n = 47), topotecan (n = 185), or amrubicin … ), and intended chemotherapy (topotecan/amrubicin vs lurbinectedin … extensive stage small cell lung cancer. FDA. November 19, … Tarlatamab in small-cell lung cancer after platinum-based chemotherapy …

… with extensive-stage small cell lung cancer (ES-SCLC) with disease progression … included patients with small cell lung cancer whose disease had grown after … standard chemotherapy, which could be topotecan, lurbinectedin or amrubicin. Patients stayed …

… with extensive stage small cell lung cancer (ES-SCLC) with disease progression … standard of care (SOC) chemotherapy (topotecan, lurbinectedin, or amrubicin) until disease …

… for the Study of Lung Cancer (IASLC) SCLC committee … treatment in the form of topotecan, amrubicin, or lurbinectedin … Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer; September … with relapsed small cell lung cancer (IDeate-Lung02). Clinical …

Among patients with small cell lung cancer (SCLC), treatment with Imdelltra (tarlatamab- … patients), which included options of topotecan (185 patients), lurbinectedin (47 … (2L) treatment for small cell lung cancer (SCLC): Outcomes by chemotherapy-free …